AXIM Biotechnologies
AXIM Biotechnologies is a biotechnology company focused on research, development and production of diagnostic and therapeutic solutions in oncology and infectious disease. It develops rapid diagnostics, including NeuCovix, which measures functional neutralizing antibodies against SARS-CoV-2, and pursues tests for early cancer detection. The company also develops proprietary small-molecule drugs to treat cancer and inhibit metastasis. Operating as a vertically integrated entity, AXIM Biotechnologies covers discovery, diagnostics and pharmaceutical development, and maintains a portfolio of intellectual property to support its oncology and infectious-disease initiatives. The company was founded in 2010 and is headquartered in San Diego, California.
Top Regions
Top Stages
1 past transactions
Sapphire Biotech
Acquisition in 2020
Sapphire Biotech, Inc. is a research and development company based in San Diego, California, focused on improving global cancer care. Established in 2019, the company specializes in creating proprietary therapeutics aimed at inhibiting cancer growth and metastasis. In addition to its therapeutic initiatives, Sapphire Biotech is also engaged in the development of innovative diagnostics designed for early cancer detection, monitoring treatment responses, and assessing recurrence. Through these efforts, the company seeks to enhance patient outcomes and advance the field of oncology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.